| HGNC Family | Metallothioneins (MT) |
| Name | metallothionein 2A |
| Description | This gene is a member of the metallothionein family of genes. Proteins encoded by this gene family are low in molecular weight, are cysteine-rich, lack aromatic residues, and bind divalent heavy metal ions, altering the intracellular concentration of heavy metals in the cell. These proteins act as anti-oxidants, protect against hydroxyl free radicals, are important in homeostatic control of metal in the cell, and play a role in detoxification of heavy metals. The encoded protein interacts with the protein encoded by the homeobox containing 1 gene in some cell types, controlling intracellular zinc levels, affecting apoptotic and autophagy pathways. Some polymorphisms in this gene are associated with an increased risk of cancer. [provided by RefSeq, Sep 2017] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMT2A functions as a pivotal regulator of cellular metal homeostasis, particularly for zinc, by binding metal ions and undergoing conformational transitions that govern zinc sequestration and release. Under both basal and oxidative stress conditions, MT2A can form disulfide bonds that facilitate additional zinc release, thereby modulating the activity of zinc‐dependent enzymes and antioxidant defenses. Its dynamic metal‐binding properties also enable the efficient trafficking of zinc to organelles such as mitochondria, which is essential for maintaining intracellular metabolic balance and protecting cells from metal‐induced toxicity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its role in metal regulation, MT2A critically influences cell survival pathways and the modulation of apoptosis and proliferation in various pathological settings. Aberrant MT2A expression has been shown to promote tumor cell invasion and chemoresistance through the upregulation of matrix metalloproteinases and modulation of transcription factors such as NF‐κB, while its downregulation can restore p53 folding and transcriptional activity, thereby inducing cell cycle arrest and apoptosis. Interactions with proteins such as ECRG2, HMBOX1, and PKCμ further underscore its multifaceted role in controlling growth and survival, ultimately contributing to the aggressiveness observed in certain cancers and providing a potential target for therapeutic intervention."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMT2A’s protective roles extend to the modulation of heavy-metal toxicokinetics and the regulation of its own expression through genetic polymorphisms and transcriptional control, thereby impacting a spectrum of clinical conditions. Variants in the MT2A promoter have been associated with altered accumulation of toxic metals such as cadmium and lead in tissues—including the kidney, prostate, placenta, and vascular endothelium—and with consequent risks for type 2 diabetes, cardiovascular complications, renal dysfunction, and various cancers. Moreover, MT2A transcription is dynamically regulated by xenobiotic-responsive factors such as the aryl hydrocarbon receptor (AHR) and glucocorticoid receptor (GR), as well as by other modulators like myeloid zinc-finger 1 (MZF1) and XIAP-associated factor 1 (XAF1), which together fine-tune its expression in response to oxidative, inflammatory, and environmental stresses. This multilayered regulation underscores the multifaceted role of MT2A in maintaining intracellular metal balance and protecting against metal-induced cytotoxicity, with wide-ranging implications for tissue homeostasis and disease susceptibility."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "15", "end_ref": "35"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Wenke Feng, Frederick W Benz, Jian Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metallothionein disulfides are present in metallothionein-overexpressing transgenic mouse heart and increase under conditions of oxidative stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M506956200"}], "href": "https://doi.org/10.1074/jbc.M506956200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16243847"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16243847"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Fimmie Reinecke, Oksana Levanets, Yolanda Olivier, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metallothionein isoform 2A expression is inducible and protects against ROS-mediated cell death in rotenone-treated HeLa cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem J (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BJ20051253"}], "href": "https://doi.org/10.1042/BJ20051253"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16402917"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16402917"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Eugenio Mocchegiani, Mario Muzzioli, Robertina Giacconi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metallothioneins/PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mech Ageing Dev (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0047-6374(03)00023-x"}], "href": "https://doi.org/10.1016/s0047-6374(03"}, {"type": "t", "text": "00023-x) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12714254"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12714254"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Shu-Hua Chen, Liuxi Chen, David H Russell "}, {"type": "b", "children": [{"type": "t", "text": "Metal-induced conformational changes of human metallothionein-2A: a combined theoretical and experimental study of metal-free and partially metalated intermediates."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Am Chem Soc (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/ja5047878"}], "href": "https://doi.org/10.1021/ja5047878"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24918957"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24918957"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Antonia A Nemec, George D Leikauf, Bruce R Pitt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nickel mobilizes intracellular zinc to induce metallothionein in human airway epithelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Respir Cell Mol Biol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1165/rcmb.2008-0409OC"}], "href": "https://doi.org/10.1165/rcmb.2008-0409OC"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19097988"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19097988"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Leslie C Costello, Zhixin Guan, Renty B Franklin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metallothionein can function as a chaperone for zinc uptake transport into prostate and liver mitochondria."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Inorg Biochem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jinorgbio.2004.02.005"}], "href": "https://doi.org/10.1016/j.jinorgbio.2004.02.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15041247"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15041247"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Yongping Cui, Jianbo Wang, Xinyu Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ECRG2, a novel candidate of tumor suppressor gene in the esophageal carcinoma, interacts directly with metallothionein 2A and links to apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0006-291x(03)00122-0"}], "href": "https://doi.org/10.1016/s0006-291x(03"}, {"type": "t", "text": "00122-0) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12646258"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12646258"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "HanLin Ma, Le Su, HongWei Yue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HMBOX1 interacts with MT2A to regulate autophagy and apoptosis in vascular endothelial cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep15121"}], "href": "https://doi.org/10.1038/srep15121"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26456220"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26456220"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Mutsushi Yamasaki, Takeo Nomura, Fuminori Sato, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2007)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17914565"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17914565"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Rosa Puca, Lavinia Nardinocchi, Gianluca Bossi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2008.10.018"}], "href": "https://doi.org/10.1016/j.yexcr.2008.10.018"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18996371"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18996371"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Daina Lim, Koh Mei-Xin Jocelyn, George Wai-Cheong Yip, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Silencing the Metallothionein-2A gene inhibits cell cycle progression from G1- to S-phase involving ATM and cdc25A signaling in breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2008.10.038"}], "href": "https://doi.org/10.1016/j.canlet.2008.10.038"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19062161"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19062161"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Prema S Rao, Meena Jaggi, David J Smith, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metallothionein 2A interacts with the kinase domain of PKCmu in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2003.09.118"}], "href": "https://doi.org/10.1016/j.bbrc.2003.09.118"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14550308"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14550308"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Kayoko Kita, Nobuhiko Miura, Minoru Yoshida, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Potential effect on cellular response to cadmium of a single-nucleotide A --> G polymorphism in the promoter of the human gene for metallothionein IIA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Genet (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00439-006-0238-6"}], "href": "https://doi.org/10.1007/s00439-006-0238-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16927099"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16927099"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Wanli Xue, Qiuqu Liu, Lu Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Stable overexpression of human metallothionein-IIA in a heart-derived cell line confers oxidative protection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Toxicol Lett (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.toxlet.2009.03.007"}], "href": "https://doi.org/10.1016/j.toxlet.2009.03.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19433272"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19433272"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Robertina Giacconi, Catia Cipriano, Elisa Muti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: relationship with inflammation (IL-6) and zinc."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biogerontology (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10522-005-4907-y"}], "href": "https://doi.org/10.1007/s10522-005-4907-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16518702"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16518702"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Lina Yang, Hongyan Li, Ting Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms in metallothionein-1 and -2 genes associated with the risk of type 2 diabetes mellitus and its complications."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Endocrinol Metab (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpendo.90234.2008"}], "href": "https://doi.org/10.1152/ajpendo.90234.2008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18349110"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18349110"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Zeliha Kayaaltı, Vugar Aliyev, Tülin Söylemezoğlu "}, {"type": "b", "children": [{"type": "t", "text": "The potential effect of metallothionein 2A -5A/G single nucleotide polymorphism on blood cadmium, lead, zinc and copper levels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Toxicol Appl Pharmacol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.taap.2011.06.023"}], "href": "https://doi.org/10.1016/j.taap.2011.06.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21767559"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21767559"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Yuanming Pan, Jiaqiang Huang, Rui Xing, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metallothionein 2A inhibits NF-κB pathway activation and predicts clinical outcome segregated with TNM stage in gastric cancer patients following radical resection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Transl Med (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1479-5876-11-173"}], "href": "https://doi.org/10.1186/1479-5876-11-173"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23870553"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23870553"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Bozena Werynska, Bartosz Pula, Beata Muszczynska-Bernhard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Mol Pathol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexmp.2012.10.006"}], "href": "https://doi.org/10.1016/j.yexmp.2012.10.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23064051"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23064051"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Zeliha Kayaalti, Görkem Mergen, Tülin Söylemezoğlu "}, {"type": "b", "children": [{"type": "t", "text": "Effect of metallothionein core promoter region polymorphism on cadmium, zinc and copper levels in autopsy kidney tissues from a Turkish population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Toxicol Appl Pharmacol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.taap.2010.03.007"}], "href": "https://doi.org/10.1016/j.taap.2010.03.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20303360"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20303360"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Scott C Wesselkamper, Susan A McDowell, Mario Medvedovic, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of metallothionein in the pathogenesis of acute lung injury."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Respir Cell Mol Biol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1165/rcmb.2005-0248OC"}], "href": "https://doi.org/10.1165/rcmb.2005-0248OC"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16166738"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16166738"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Anna Krześlak, Ewa Forma, Paweł Jóźwiak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Exp Med (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10238-012-0215-4"}], "href": "https://doi.org/10.1007/s10238-012-0215-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23053628"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23053628"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Shoko Sato, Hitoshi Shirakawa, Shuhei Tomita, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The aryl hydrocarbon receptor and glucocorticoid receptor interact to activate human metallothionein 2A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Toxicol Appl Pharmacol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.taap.2013.08.017"}], "href": "https://doi.org/10.1016/j.taap.2013.08.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23994556"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23994556"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Shuye Lin, Xiaoyue Wang, Yuanming Pan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcription Factor Myeloid Zinc-Finger 1 Suppresses Human Gastric Carcinogenesis by Interacting with Metallothionein 2A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-18-1281"}], "href": "https://doi.org/10.1158/1078-0432.CCR-18-1281"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30301827"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30301827"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Anna Krześlak, Ewa Forma, Grażyna Chwatko, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Toxicol Appl Pharmacol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.taap.2013.02.013"}], "href": "https://doi.org/10.1016/j.taap.2013.02.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23466427"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23466427"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Deniz Tekin, Zeliha Kayaaltı, Vugar Aliyev, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The effects of metallothionein 2A polymorphism on placental cadmium accumulation: Is metallothionein a modifiying factor in transfer of micronutrients to the fetus?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Appl Toxicol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jat.1661"}], "href": "https://doi.org/10.1002/jat.1661"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21328412"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21328412"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Cheol-Hee Shin, Min-Goo Lee, Jikhyon Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1700861114"}], "href": "https://doi.org/10.1073/pnas.1700861114"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28507149"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28507149"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Deniz Tekin, Zeliha Kayaaltı, Tülin Söylemezoğlu "}, {"type": "b", "children": [{"type": "t", "text": "The effects of metallothionein 2A polymorphism on lead metabolism: are pregnant women with a heterozygote genotype for metallothionein 2A polymorphism and their newborns at risk of having higher blood lead levels?"}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int Arch Occup Environ Health (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00420-011-0711-y"}], "href": "https://doi.org/10.1007/s00420-011-0711-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22005883"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22005883"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Di Liu, Meng Wang, Tian Tian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic polymorphisms (rs10636 and rs28366003) in metallothionein 2A increase breast cancer risk in Chinese Han population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging (Albany NY) (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/aging.101177"}], "href": "https://doi.org/10.18632/aging.101177"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28228606"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28228606"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Zeliha Kayaalti, Tülin Söylemezoğlu "}, {"type": "b", "children": [{"type": "t", "text": "The polymorphism of core promoter region on metallothionein 2A-metal binding protein in Turkish population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Rep (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11033-009-9586-3"}], "href": "https://doi.org/10.1007/s11033-009-9586-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19572214"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19572214"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Ana Martinho, Isabel Gonçalves, Isabel Cardoso, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human metallothioneins 2 and 3 differentially affect amyloid-beta binding by transthyretin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS J (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1742-4658.2010.07749.x"}], "href": "https://doi.org/10.1111/j.1742-4658.2010.07749.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20646067"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20646067"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Zeliha Kayaaltı, Levent Sahiner, M Emre Durakoğlugil, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Distributions of interleukin-6 (IL-6) promoter and metallothionein 2A (MT2A) core promoter region gene polymorphisms and their associations with aging in Turkish population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Gerontol Geriatr (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.archger.2011.01.001"}], "href": "https://doi.org/10.1016/j.archger.2011.01.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21277639"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21277639"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Chen-Cheng Yang, Chih-Shien Chuang, Chia-I Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The association of the blood lead level and serum lipid concentrations may be modified by the genetic combination of the metallothionein 2A polymorphisms rs10636 GC and rs28366003 AA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Lipidol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jacl.2016.12.010"}], "href": "https://doi.org/10.1016/j.jacl.2016.12.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28391890"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28391890"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Kelly Christine Marques Fernandes, Airton Cunha Martins, Andréia Ávila Soares de Oliveira, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphism of Metallothionein 2A Modifies Lead Body Burden in Workers Chronically Exposed to the Metal."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Public Health Genomics (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000441713"}], "href": "https://doi.org/10.1159/000441713"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26594907"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26594907"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Yuta Hattori, Mariko Naito, Masahiko Satoh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Metallothionein MT2A A-5G Polymorphism as a Risk Factor for Chronic Kidney Disease and Diabetes: Cross-Sectional and Cohort Studies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Toxicol Sci (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/toxsci/kfw080"}], "href": "https://doi.org/10.1093/toxsci/kfw080"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27122239"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27122239"}]}]}]}
|
| Synonyms | MT-2, MT2, MT-II |
| Proteins | MT2_HUMAN |
| NCBI Gene ID | 4502 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MT2A has 24,144 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 112 datasets.
Click the + buttons to view associations for MT2A from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of MT2A gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MT2A gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of MT2A gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of MT2A gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of MT2A gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MT2A gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of MT2A gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MT2A gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of MT2A gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with MT2A protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with MT2A gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MT2A gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MT2A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of MT2A gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of MT2A gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MT2A gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing MT2A protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with MT2A protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with MT2A protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MT2A gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with MT2A gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with MT2A gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with MT2A gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of MT2A protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by MT2A gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for MT2A protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with MT2A gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with MT2A gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with MT2A gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with MT2A gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for MT2A protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MT2A gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MT2A gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MT2A gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing MT2A from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with MT2A gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with MT2A gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of MT2A gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MT2A gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MT2A from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of MT2A gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MT2A gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of MT2A gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MT2A gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of MT2A gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of MT2A gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving MT2A gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving MT2A gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving MT2A gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing MT2A protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing MT2A protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing MT2A protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by MT2A gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by MT2A gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by MT2A gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MT2A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of MT2A gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MT2A gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of MT2A gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of MT2A gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of MT2A gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MT2A gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with MT2A gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with MT2A gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by MT2A gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for MT2A protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of MT2A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MT2A gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways 2026 | pathways involving MT2A protein from the KEGG Pathways 2026 dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MT2A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of MT2A gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with MT2A gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MT2A gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of MT2A gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of MT2A gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MT2A gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain MT2A protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MT2A gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MT2A gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of MT2A gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of MT2A gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of MT2A gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing MT2A protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for MT2A from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MT2A gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of MT2A gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving MT2A protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving MT2A protein from the Wikipathways PFOCR 2024 dataset. | |
| PID Pathways | pathways involving MT2A protein from the PID Pathways dataset. | |
| Reactome Pathways 2014 | pathways involving MT2A protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving MT2A protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MT2A gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MT2A gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MT2A gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of MT2A gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MT2A gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MT2A gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of MT2A gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of MT2A gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of MT2A gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of MT2A gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of MT2A gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of MT2A gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of MT2A gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of MT2A gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of MT2A protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MT2A protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of MT2A protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MT2A protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with MT2A protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with MT2A protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving MT2A protein from the WikiPathways Pathways 2024 dataset. | |